These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 19485299)
21. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration]. Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910 [TBL] [Abstract][Full Text] [Related]
22. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study. Szeto SKH; Tsang CW; Mohamed S; Lee GKY; Lok JKH; Hui VWK; Tsang KK; Chen LJ; Brelen M; Lai TYY Ophthalmologica; 2024; 247(2):118-132. PubMed ID: 38408445 [TBL] [Abstract][Full Text] [Related]
23. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature. Stanescu-Segall D; Balta F; Jackson TL Surv Ophthalmol; 2016; 61(1):18-32. PubMed ID: 26212151 [TBL] [Abstract][Full Text] [Related]
24. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629 [TBL] [Abstract][Full Text] [Related]
26. [Management of subretinal hemorrhage with r-TPA, SF-6 and ranibizumab]. Gros-Otero J; Benítez-Herreros J; Beckford-Torngren C; Cámara-González C; Castro-Rebollo M Arch Soc Esp Oftalmol; 2010 Mar; 85(3):114-7. PubMed ID: 20619123 [TBL] [Abstract][Full Text] [Related]
27. Preoperative use of tissue plasminogen activator for large submacular hemorrhage. Chaudhry NA; Mieler WF; Han DP; Alfaro VD; Liggett PE Ophthalmic Surg Lasers; 1999 Mar; 30(3):176-80. PubMed ID: 10100249 [TBL] [Abstract][Full Text] [Related]
28. Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent. de Silva SR; Bindra MS Eye (Lond); 2016 Jul; 30(7):952-7. PubMed ID: 27080482 [TBL] [Abstract][Full Text] [Related]
29. Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results. Boiché M; Angioi-Duprez K; Conart JB; Berrod JP J Fr Ophtalmol; 2019 Nov; 42(9):e391-e397. PubMed ID: 31471124 [TBL] [Abstract][Full Text] [Related]
30. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator. Cakir M; Cekiç O; Yilmaz OF Eur J Ophthalmol; 2010; 20(3):565-71. PubMed ID: 20037915 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration. Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood. Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361 [TBL] [Abstract][Full Text] [Related]
33. Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage. Shin JY; Choi HJ; Chung B; Choi M; Lee J; Byeon SH Optom Vis Sci; 2016 Feb; 93(2):173-80. PubMed ID: 26704146 [TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Treumer F; Roider J; Hillenkamp J Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095 [TBL] [Abstract][Full Text] [Related]
36. Modified Approach in Management of Submacular Hemorrhage Secondary to Wet Age-Related Macular Degeneration. Kumar A; Roy S; Bansal M; Tinwala S; Aron N; Temkar S; Pujari A Asia Pac J Ophthalmol (Phila); 2016; 5(2):143-6. PubMed ID: 26302314 [TBL] [Abstract][Full Text] [Related]
37. Visual prognosis of massive submacular hemorrhage in polypoidal choroidal vasculopathy with or without combination treatment. Lin TC; Hwang DK; Lee FL; Chen SJ J Chin Med Assoc; 2016 Mar; 79(3):159-65. PubMed ID: 26775600 [TBL] [Abstract][Full Text] [Related]
38. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage. Shin JY; Lee JM; Byeon SH Am J Ophthalmol; 2015 May; 159(5):904-14.e1. PubMed ID: 25637179 [TBL] [Abstract][Full Text] [Related]
39. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience. Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581 [TBL] [Abstract][Full Text] [Related]